🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
61.36
-0.63 (-1.02%)
At close: Nov 19, 2026, 4:00 PM EST
60.14
-1.22 (-1.99%)
After-hours: Nov 19, 2026, 4:44 PM EST

Eton Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Eton Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $80.75. The average 1-year stock price forecast is 31.60% higher than the current stock price, while the lowest is $80 (+30.38%) and the highest is $82 (+33.64%).

Price Target: $80.75 (+31.60%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$80$80.75$80.5$82
Change+30.38%+31.60%+31.19%+33.64%

Analyst Ratings

The average analyst rating for Eton Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy344444
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total344444

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
B. Riley Securities
B. Riley Securities
Buy
Maintains
$70 → $81
BuyMaintains$70 → $81+32.01%Nov 10, 2026
Craig-Hallum
Craig-Hallum
Buy
Maintains
$78 → $82
BuyMaintains$78 → $82+33.64%Nov 6, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$68 → $80
BuyReiterates$68 → $80+30.38%Nov 6, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$70 → $80
BuyMaintains$70 → $80+30.38%Nov 6, 2026

Financial Forecast

Revenue This Year
179.91M
from 79.95M
Increased by 125.03%
Revenue Next Year
286.90M
from 179.91M
Increased by 59.47%
EPS This Year
1.78
from 0.32
Increased by 454.69%
EPS Next Year
3.31
from 1.78
Increased by 86.20%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
21.83M21.25M31.64M39.01M79.95M179.91M
Revenue Growth
55,879.49%-2.66%48.90%23.29%104.94%125.03%
Gross Profit
19.01M14.32M21.06M23.41M47.83M126.84M
Gross Margin
87.05%67.38%66.56%60.01%59.83%70.50%
Operating Income
-1.50M-8.26M-1.19M-2.18M4.83M57.61M
Net Income
-1.96M-9.02M-936.00K-3.82M-4.60M65.85M
EPS
----0.321.78
EPS Growth
-----454.69%
Forward PE
9.9832.8579.6457.9130.5634.57
Free Cash Flow
----10.19M52.51M
No. Analysts
-----4
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High182.0M
Avg179.9M
Low178.1M

Revenue Growth

Revenue Growth202620272028
High
127.6%
Avg
125.0%
Low
122.8%

EPS Forecast

EPS202620272028
High1.87
Avg1.78
Low1.68

EPS Growth

EPS Growth202620272028
High
484.4%
Avg
454.7%
Low
425.0%